Niagen BiosciencevsSherwin-Williams

NAGE and SHW stock compared: price, dividend, valuation and results, from SEC filings.

SHW

The Sherwin-Williams Company

$340.92

Value $84.5B

-1.70%
SHW's page

Niagen Bioscience (NAGE) has a market value of $151M and Sherwin-Williams (SHW) $84.5B. Over the last year, with dividends, NAGE moved -72.4% and SHW +6.2%. The P/E is 14.8 for NAGE and 31.6 for SHW. Dividend yield: NAGE none, SHW 0.94%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    NAGE$151M

    SHW$84.5B

    SHW is 558 times NAGE

  • Revenue, 12 months

    NAGE$122M

    SHW$24.9B

    SHW is 204 times NAGE

  • Net income, 12 months

    NAGE$10M

    SHW$2.7B

    SHW is 261 times NAGE

  • Operating margin

    NAGE3.9%

    SHW–

  • ROIC

    NAGE5.6%

    SHW17.7%

    12.1 points apart

  • P/E

    NAGE14.8

    SHW31.6

    SHW is 2.1 times NAGE

  • Dividend yield

    NAGE0.0%

    SHW0.9%

    0.9 points apart

  • 5-year return

    NAGE-65.6%

    SHW+7.8%

    73.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

NAGE-65.6%

SHW+7.8%

10020020222023202420252026
Returns by period
PeriodNAGEWith dividendsSHWWith dividends
1 year since November 18, 2025-72.4%Price -72.4%+6.2%Price +5.2%
3 years since November 17, 2023+32.2%+9.7% a yearPrice +32.2%+29.4%+9.0% a yearPrice +26.0%
5 years since November 18, 2021-65.6%-19.2% a yearPrice -65.6%+7.8%+1.5% a yearPrice +3.0%
10 years since November 21, 2016-24.1%-2.7% a yearPrice -24.1%+320.3%+15.4% a yearPrice +284.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

NAGENiagen BioscienceSHWSherwin-Williams

Valuation

NAGESHW
Valuation
Price$1.89$340.92
Market value$151M$84.5B
Enterprise value (EV)$82M$94.5B
P/E14.831.6
P/E, 5-year median–32.2
P/B1.821.2
EV/EBIT17.127.0
Free cash flow yield–3.6%

Results and growth

NAGESHW
Results and growth
Revenue, 12 months$122M$24.9B
Net income, 12 months$10M$2.7B
Free cash flow, 12 months–$3.1B
Earnings per share, 12 months$0.12$10.88
Revenue growth, year on year30.0%2.1%
Revenue growth a year, past+16.9%over 5 years+5.1%over 5 years
EPS growth a year, past–+6.9%over 5 years

Margins and returns on capital

NAGESHW
Margins and returns on capital
Gross margin63.9%48.6%
Operating margin3.9%–
Net margin8.4%10.7%
ROIC5.6%17.7%
ROE13.0%62.9%

Balance sheet

NAGESHW
Balance sheet
Cash$70M$264M
Total debt$2.1M$12.5B
Net debt / EBITDA-12.92.6
Interest cover–6.5×

Dividends and buybacks

NAGESHW
Dividends and buybacks
Dividend yield–0.9%
Dividend per share, 12 months–$3.20
Dividend growth a year, past–+12.1%over 5 years
Buyback yield0.2%2.0%
Shareholder yield0.2%2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: NAGE or SHW

Didn't find what you were looking for?

Ask us
Which is bigger, Niagen Bioscience or Sherwin-Williams?

By market value, Sherwin-Williams ($84.5B) is about 558.1 times Niagen Bioscience ($151M), at today's prices.

How did NAGE and SHW stock do over the last 10 years?

Since November 21, 2016, NAGE's price moved -24.1% and SHW's +284.0%. With dividends: NAGE -24.1% (-2.7% a year), SHW +320.3% (+15.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, NAGE or SHW?

The dividend yield at today's price is none for Niagen Bioscience and 0.94% for Sherwin-Williams. Over the last twelve months they paid – and $3.20 per share.

What is the P/E of NAGE and SHW?

At today's price, the P/E is 14.8 for NAGE and 31.6 for SHW. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Niagen Bioscience or Sherwin-Williams?

Over the last twelve months, the net margin was 8.4% for Niagen Bioscience and 10.7% for Sherwin-Williams, and the operating margin 3.9% and –. Revenue was $122M and $24.9B.

Which is the better investment, Niagen Bioscience or Sherwin-Williams?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.